Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy - PubMed (original) (raw)
. 2008 Jul;142(1):126-35.
doi: 10.1111/j.1365-2141.2008.07155.x. Epub 2008 Apr 17.
Affiliations
- PMID: 18422994
- DOI: 10.1111/j.1365-2141.2008.07155.x
Free article
Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy
Maxwell Westerman et al. Br J Haematol. 2008 Jul.
Free article
Abstract
Levels of circulating red blood cell (RBC)-derived vesicles are increased in sickle cell anaemia (SCA) and thalassaemia intermedia (TI) but the mechanisms, effects and controlling factors may differ. This study found that levels of vesicles and intravascular haemolysis were linked as shown by the correlation between levels of vesicles and plasma Hb. Vesicle levels were 6-fold greater in SCA and 4-fold greater in TI than in controls. The proportion of plasma Hb within vesicles was increased in SCA and TI with a significantly higher proportion in TI. We examined whether subpopulations of RBC expressing phosphatidylserine (PS) were a source of PS(+) vesicles and observed a significant association. Thrombin generation was promoted by the vesicles in which 40-50% expressed PS. In TI, markers of thrombin generation were significantly related to PS(+) RBC. Splenectomy in TI had significant effects including greater increases in vesicle levels, plasma Hb, PS(+) RBCs and thrombin generation markers than in unsplenectomised patients. In hydroxycarbamide (HC)-treated SCA patients these measures were decreased compared with untreated controls. The relationship between vesicle levels and plasma Hb suggests a mechanism linking vesiculation to haemolysis and consequently nitric oxide (NO) bioavailability and suggests a means by which HC treatment improves NO bioavailability.
Similar articles
- Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability.
Ataga KI, Cappellini MD, Rachmilewitz EA. Ataga KI, et al. Br J Haematol. 2007 Oct;139(1):3-13. doi: 10.1111/j.1365-2141.2007.06740.x. Br J Haematol. 2007. PMID: 17854302 Review. - The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
Gerotziafas GT, Van Dreden P, Chaari M, Galea V, Khaterchi A, Lionnet F, Stankovic-Stojanovic K, Blanc-Brude O, Woodhams B, Maier-Redelsperger M, Girot R, Hatmi M, Elalamy I. Gerotziafas GT, et al. Thromb Haemost. 2012 Jun;107(6):1044-52. doi: 10.1160/TH11-10-0689. Epub 2012 Apr 26. Thromb Haemost. 2012. PMID: 22535498 - Hemostatic alterations in sickle cell disease: relationships to disease pathophysiology.
Stuart MJ, Setty BN. Stuart MJ, et al. Pediatr Pathol Mol Med. 2001 Jan-Feb;20(1):27-46. Pediatr Pathol Mol Med. 2001. PMID: 12673843 Review. - Haemolysis and abnormal haemorheology in sickle cell anaemia.
Connes P, Lamarre Y, Waltz X, Ballas SK, Lemonne N, Etienne-Julan M, Hue O, Hardy-Dessources MD, Romana M. Connes P, et al. Br J Haematol. 2014 May;165(4):564-72. doi: 10.1111/bjh.12786. Epub 2014 Feb 24. Br J Haematol. 2014. PMID: 24611951 - Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
Whelihan MF, Lim MY, Mooberry MJ, Piegore MG, Ilich A, Wogu A, Cai J, Monroe DM, Ataga KI, Mann KG, Key NS. Whelihan MF, et al. J Thromb Haemost. 2016 Oct;14(10):1941-1952. doi: 10.1111/jth.13416. Epub 2016 Aug 31. J Thromb Haemost. 2016. PMID: 27430959
Cited by
- Pregnancy outcomes and iron status in β-thalassemia major and intermedia: a systematic review and meta-analysis.
Vlachodimitropoulou E, Mogharbel H, Kuo KHM, Hwang M, Ward R, Shehata N, Malinowski AK. Vlachodimitropoulou E, et al. Blood Adv. 2024 Feb 13;8(3):746-757. doi: 10.1182/bloodadvances.2023011636. Blood Adv. 2024. PMID: 38181780 Free PMC article. - Plasma concentration of platelet-derived microparticles is related to painful vaso-occlusive phenotype severity in sickle cell anemia.
Nebor D, Bowers A, Connes P, Hardy-Dessources MD, Knight-Madden J, Cumming V, Reid M, Romana M. Nebor D, et al. PLoS One. 2014 Jan 24;9(1):e87243. doi: 10.1371/journal.pone.0087243. eCollection 2014. PLoS One. 2014. PMID: 24475257 Free PMC article. - Extracellular Vesicles in Sickle Cell Disease: Plasma Concentration, Blood Cell Types Origin Distribution and Biological Properties.
Nader E, Garnier Y, Connes P, Romana M. Nader E, et al. Front Med (Lausanne). 2021 Aug 20;8:728693. doi: 10.3389/fmed.2021.728693. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34490315 Free PMC article. Review. - Differences of microparticle patterns between sickle cell anemia and hemoglobin SC patients.
Garnier Y, Ferdinand S, Etienne-Julan M, Elana G, Petras M, Doumdo L, Tressières B, Lalanne-Mistrih ML, Hardy-Dessources MD, Connes P, Romana M. Garnier Y, et al. PLoS One. 2017 May 10;12(5):e0177397. doi: 10.1371/journal.pone.0177397. eCollection 2017. PLoS One. 2017. PMID: 28489923 Free PMC article. - Large red cell-derived membrane particles are major contributors to hypercoagulability in sickle cell disease.
Smith RA, Mankelow TJ, Drizou D, Bullock T, Latham T, Trompeter S, Blair A, Anstee DJ. Smith RA, et al. Sci Rep. 2021 May 26;11(1):11035. doi: 10.1038/s41598-021-90477-z. Sci Rep. 2021. PMID: 34040079 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical